McKesson (MCK) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

McKesson Revenue Highlights

Latest Revenue (Y)

$308.95B

Latest Revenue (Q)

$93.65B

Main Segment (Y)

U.S. Pharmaceutical Segment

Main Geography (Y)

International Segment

McKesson Revenue by Period

McKesson Revenue by Year

Date	Revenue	Change
2024-03-31	$308.95B	11.65%
2023-03-31	$276.71B	4.83%
2022-03-31	$263.97B	10.80%
2021-03-31	$238.23B	3.11%
2020-03-31	$231.05B	7.81%
2019-03-31	$214.32B	2.86%
2018-03-31	$208.36B	4.95%
2017-03-31	$198.53B	4.01%
2016-03-31	$190.88B	6.61%
2015-03-31	$179.04B	30.11%
2014-03-31	$137.61B	12.38%
2013-03-31	$122.45B	-0.23%
2012-03-31	$122.73B	9.50%
2011-03-31	$112.08B	3.11%
2010-03-31	$108.70B	1.94%
2009-03-31	$106.63B	4.85%
2008-03-31	$101.70B	9.39%
2007-03-31	$92.98B	5.60%
2006-03-31	$88.05B	9.36%
2005-03-31	$80.51B	15.84%
2004-03-31	$69.51B	21.68%
2003-03-31	$57.12B	14.23%
2002-03-31	$50.01B	19.03%
2001-03-31	$42.01B	14.36%
2000-03-31	$36.73B	20.91%
1999-03-31	$30.38B	45.67%
1998-03-31	$20.86B	61.85%
1997-03-31	$12.89B	-6.05%
1996-03-31	$13.72B	4.00%
1995-03-31	$13.19B	-

McKesson generated $308.95B in revenue during NA 2024, up 11.65% compared to the previous quarter, and up 144.15% compared to the same period a year ago.

McKesson Revenue by Quarter

Date	Revenue	Change
2024-09-30	$93.65B	18.12%
2024-06-30	$79.28B	3.83%
2024-03-31	$76.36B	-5.62%
2023-12-31	$80.90B	4.77%
2023-09-30	$77.22B	3.67%
2023-06-30	$74.48B	8.09%
2023-03-31	$68.91B	-2.24%
2022-12-31	$70.49B	0.47%
2022-09-30	$70.16B	4.47%
2022-06-30	$67.15B	1.59%
2022-03-31	$66.10B	-3.66%
2021-12-31	$68.61B	3.06%
2021-09-30	$66.58B	6.23%
2021-06-30	$62.67B	5.97%
2021-03-31	$59.14B	-5.52%
2020-12-31	$62.60B	2.95%
2020-09-30	$60.81B	9.21%
2020-06-30	$55.68B	-4.88%
2020-03-31	$58.53B	-1.08%
2019-12-31	$59.17B	2.70%
2019-09-30	$57.62B	3.39%
2019-06-30	$55.73B	6.29%
2019-03-31	$52.43B	-6.72%
2018-12-31	$56.21B	5.90%
2018-09-30	$53.08B	0.89%
2018-06-30	$52.61B	1.90%
2018-03-31	$51.63B	-3.71%
2017-12-31	$53.62B	2.99%
2017-09-30	$52.06B	1.98%
2017-06-30	$51.05B	4.80%
2017-03-31	$48.71B	-2.83%
2016-12-31	$50.13B	0.35%
2016-09-30	$49.96B	0.45%
2016-06-30	$49.73B	6.54%
2016-03-31	$46.68B	-2.55%
2015-12-31	$47.90B	-1.77%
2015-09-30	$48.76B	2.56%
2015-06-30	$47.55B	10.00%
2015-03-31	$43.22B	-8.04%
2014-12-31	$47.01B	5.02%
2014-09-30	$44.76B	1.59%
2014-06-30	$44.06B	15.51%
2014-03-31	$38.14B	11.18%
2013-12-31	$34.31B	4.10%
2013-09-30	$32.95B	2.32%
2013-06-30	$32.21B	5.19%
2013-03-31	$30.62B	-1.82%
2012-12-31	$31.19B	4.48%
2012-09-30	$29.85B	-3.08%
2012-06-30	$30.80B	-2.84%
2012-03-31	$31.70B	2.79%
2011-12-31	$30.84B	2.06%
2011-09-30	$30.22B	0.79%
2011-06-30	$29.98B	3.91%
2011-03-31	$28.85B	2.15%
2010-12-31	$28.25B	2.59%
2010-09-30	$27.53B	0.31%
2010-06-30	$27.45B	3.03%
2010-03-31	$26.64B	-5.76%
2009-12-31	$28.27B	4.21%
2009-09-30	$27.13B	1.77%
2009-06-30	$26.66B	1.65%
2009-03-31	$26.22B	-3.34%
2008-12-31	$27.13B	2.09%
2008-09-30	$26.57B	-0.49%
2008-06-30	$26.70B	1.80%
2008-03-31	$26.23B	-

McKesson generated $93.65B in revenue during Q2 2025, up 18.12% compared to the previous quarter, and up 125.73% compared to the same period a year ago.

McKesson Revenue Breakdown

McKesson Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
International Segment	$14.13B	$20.60B	$35.97B	-	-
U.S. Pharmaceutical Segment	$278.74B	$240.62B	$212.15B	$189.27B	-
Prescription Technology Solutions	$4.77B	$4.39B	-	-	-
Medical-Surgical Solutions Segment	$11.31B	$11.11B	$11.61B	$10.10B	-
Prescription Technology Solutions Segment	-	$4.39B	$3.86B	$2.89B	-
Medical-Surgical Solutions	-	-	-	-	$8.30B
Other Segments	-	-	-	-	$12.02B

McKesson's latest annual revenue breakdown by segment (product or service), as of Mar 24: U.S. Pharmaceutical Segment (90.22%), International Segment (4.57%), Medical-Surgical Solutions Segment (3.66%), and Prescription Technology Solutions (1.54%).

Quarterly Revenue by Product

Product/Service	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
International Segment	$3.71B	$3.55B	$3.64B	$3.48B	$3.47B	$3.36B	$4.45B	$6.24B	$6.55B	$8.53B	$9.46B	$9.11B	$9.25B	$8.60B	$9.27B	$9.54B	-	-	-	-
U.S. Pharmaceutical Segment	$85.73B	$68.79B	$73.02B	$69.77B	$67.16B	$61.68B	$61.93B	$60.06B	$56.95B	$53.68B	$55.04B	$53.41B	$50.02B	$47.04B	$49.49B	$48.07B	-	-	-	-
Prescription Technology Solutions	$1.26B	$1.18B	$1.21B	$1.14B	$1.24B	$1.12B	$1.02B	$1.07B	$1.03B	$932.00M	$881.00M	-	-	-	-	-	-	-	-	-
Medical-Surgical Solutions Segment	$2.95B	$2.84B	$3.03B	$2.83B	$2.61B	$2.69B	$2.99B	$2.84B	$2.59B	$2.87B	$3.08B	$3.12B	$2.53B	$2.71B	$3.05B	$2.53B	-	-	-	-
Prescription Technology Solutions Segment	-	-	$1.21B	$789.00M	$777.00M	$668.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Segments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$2.57B	$2.90B	$3.18B	$2.98B
Medical-Surgical Solutions	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.80B	$2.21B	$2.14B	$2.06B
U.S. Pharmaceutical and Specialty Solutions	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$45.06B	$46.27B	$46.92B	$45.98B

McKesson's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: U.S. Pharmaceutical Segment (91.54%), International Segment (3.96%), Medical-Surgical Solutions Segment (3.15%), and Prescription Technology Solutions (1.35%).

McKesson Revenue Breakdown by Country

Annual Revenue by Country

Country	Mar 24	Mar 23	Mar 20	Mar 19	Mar 18
International Segment	$14.13B	$20.60B	-	-	-
Non-US	-	-	$38.34B	$38.02B	$38.41B
UNITED STATES	-	-	$192.71B	$176.30B	$169.94B

McKesson's latest annual revenue breakdown by geography, as of Mar 24: International Segment (100.00%).

Quarterly Revenue by Country

Country	Sep 24	Mar 24	Dec 23	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Dec 18	Sep 18	Jun 18
International Segment	$3.71B	$3.55B	$3.64B	-	-	-	-	-	-	-	-	-
Non-US	-	-	-	$8.55B	$9.75B	$9.86B	$9.32B	$9.41B	$9.32B	$9.69B	$9.30B	$9.72B
UNITED STATES	-	-	-	$47.13B	$48.78B	$49.31B	$48.29B	$46.32B	$43.11B	$46.52B	$43.77B	$42.89B

McKesson's latest quarterly revenue breakdown by geography, as of Sep 24: International Segment (100.00%).

McKesson Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
MCK	McKesson	$308.95B	$93.65B
ABC	Cencora	$262.17B	$74.24B
CAH	Cardinal Health	$205.01B	$52.28B
HSIC	Henry Schein	$12.34B	$3.14B
OMI	Owens & Minor	$10.33B	$2.72B
PDCO	Patterson Companies	$6.57B	$1.54B
ZYXI	Zynex	$184.32M	$49.97M
EDAP	EDAP TMS	$59.18M	$15.00M

MCK Revenue FAQ

What is McKesson’s yearly revenue?

McKesson's yearly revenue for 2024 was $308.95B, representing an increase of 11.65% compared to 2023. The company's yearly revenue for 2023 was $276.71B, representing an increase of 4.83% compared to 2022. MCK's yearly revenue for 2022 was $263.97B, representing an increase of 10.80% compared to 2021.

What is McKesson’s quarterly revenue?

McKesson's quarterly revenue for Q2 2025 was $93.65B, a 18.12% increase from the previous quarter (Q1 2025), and a 21.29% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $79.28B, a 3.83% increase from the previous quarter (Q4 2024), and a 6.44% increase year-over-year (Q1 2024). MCK's quarterly revenue for Q4 2024 was $76.36B, a -5.62% decrease from the previous quarter (Q3 2024), and a 10.80% increase year-over-year (Q4 2023).

What is McKesson’s revenue growth rate?

McKesson's revenue growth rate for the last 3 years (2022-2024) was 17.04%, and for the last 5 years (2020-2024) was 33.72%.

What are McKesson’s revenue streams?

McKesson's revenue streams in r 24 are International Segment, U.S. Pharmaceutical Segment, Prescription Technology Solutions, and Medical-Surgical Solutions Segment. International Segment generated $14.13B in revenue, accounting 4.57% of the company's total revenue, down -31.40% year-over-year. U.S. Pharmaceutical Segment generated $278.74B in revenue, accounting 90.22% of the company's total revenue, up 15.84% year-over-year. Prescription Technology Solutions generated $4.77B in revenue, accounting 1.54% of the company's total revenue, up 8.71% year-over-year. Medical-Surgical Solutions Segment generated $11.31B in revenue, accounting 3.66% of the company's total revenue, up 1.83% year-over-year.

What is McKesson’s main source of revenue?

For the fiscal year ending Mar 24, the largest source of revenue of McKesson was U.S. Pharmaceutical Segment. This segment made a revenue of $278.74B, representing 90.22% of the company's total revenue.